Cargando…
Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes
Due to synergistic effects, combinatorial drugs are widely used for treating complex diseases. However, combining drugs and making them synergetic remains a challenge. Genetic disease genes are considered a promising source of drug targets with important implications for navigating the drug space. M...
Autores principales: | Quan, Yuan, Liu, Meng-Yuan, Liu, Ye-Mao, Zhu, Li-Da, Wu, Yu-Shan, Luo, Zhi-Hui, Zhang, Xiu-Zhen, Xu, Shi-Zhong, Yang, Qing-Yong, Zhang, Hong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017788/ https://www.ncbi.nlm.nih.gov/pubmed/29570606 http://dx.doi.org/10.3390/molecules23040736 |
Ejemplares similares
-
Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
por: Xu, Xuan, et al.
Publicado: (2021) -
Epistatic Association Mapping in Homozygous Crop Cultivars
por: Lü, Hai-Yan, et al.
Publicado: (2011) -
RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
por: Wang, Lei, et al.
Publicado: (2021) -
Epistatic Association Mapping for Alkaline and Salinity Tolerance Traits in the Soybean Germination Stage
por: Zhang, Wen-Jie, et al.
Publicado: (2014) -
Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer
por: Zhao, Xiaoyu, et al.
Publicado: (2021)